1.
J Am Acad Dermatol
; 83(1): 295-296, 2020 Jul.
Article
in English
| MEDLINE | ID: covidwho-186397
Subject(s)
Betacoronavirus/pathogenicity , Coronavirus Infections/prevention & control , Dermatology/standards , Medical Oncology/standards , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Skin Neoplasms/therapy , Betacoronavirus/immunology , COVID-19 , Chemotherapy, Adjuvant/standards , Coronavirus Infections/epidemiology , Coronavirus Infections/transmission , Coronavirus Infections/virology , Dermatology/methods , Humans , Immunotherapy/adverse effects , Immunotherapy/standards , Infection Control/standards , Infusions, Intravenous/standards , Medical Oncology/methods , Mohs Surgery/standards , Neoadjuvant Therapy/standards , Pneumonia, Viral/epidemiology , Pneumonia, Viral/transmission , Pneumonia, Viral/virology , Risk Assessment/standards , SARS-CoV-2 , Skin/pathology , Skin Neoplasms/immunology , Skin Neoplasms/pathology , Telemedicine/standards
2.
Gastroenterology
; 159(1): 350-357, 2020 Jul.
Article
in English
| MEDLINE | ID: covidwho-46654
ABSTRACT
The purpose of this American Gastroenterological Association (AGA) Institute Clinical Practice Update was to rapidly review the emerging evidence and provide timely expert recommendations regarding the management of patients with inflammatory bowel disease during the coronavirus disease 2019 pandemic. This expert commentary was commissioned and approved by the AGA Institute Clinical Practice Updates Committee and the AGA Governing Board to provide timely perspective on a topic of high clinical importance to the AGA membership, and underwent internal peer review by the Clinical Practice Updates Committee and external peer review through standard procedures of Gastroenterology.